Corcept Therapeutics Inc
CORT
ISIN null / Valor 1812837
Corcept Therapeutics Inc
UMushroom community rating:
About company
Corcept Therapeutics Inc. is a biopharmaceutical company focused on therapies that modulate the glucocorticoid receptor to treat diseases driven by excess cortisol signaling; it commercializes Korlym (mifepristone) in the United States for control of hyperglycemia in patients with endogenous Cushing’s syndrome who are not candidates for surgery and generates revenue from product sales while advancing a pipeline of selective glucocorticoid receptor modulators, most notably relacorilant, which is being evaluated in Cushing’s and in combination regimens for certain solid tumors. The company’s operations combine clinical development, regulatory work and commercial activities to pursue additional indications for its marketed product and to progress investigational GR-targeting candidates, and it is publicly traded on NASDAQ under the ticker CORT.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
11974 M
Market cap (USD)
769,043
Daily traded volume (Shares)
51.95 / 50.17
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
